Trial counsel in Grantley v. Clear Channel Communications, Inc., a patent infringement case in which a federal jury in the Eastern District of Texas awarded Grantley Corporation $66 million. The jury found that Clear Channel Communications, Inc. infringed on four of Grantley Corporation's patents related to an integrated inventory management system for radio advertising time. The jury also found that the infringement was willful. The verdict was announced on April 22, 2008. On June 11, 2008, the court enhanced the damages by more than $16.5 million, awarded prejudgment interest and entered judgment totaling more than $89 million. The case settled while on appeal under confidential terms.

Wyeth v. Teva Pharmaceuticals USA, Inc., No. 03-CV-1293 (D. N.J.) (with previous firm). Integral member of litigation team that represented Teva in defending against Wyeth's assertions of patent infringement in response to Teva's bid to market generic venlafaxine hydrochloride extended release capsules, a popular antidepressant sold by Wyeth as Effexor XR.  After a Markman ruling and while the Court's ruling on a summary judgment motion was pending, on the eve of trial, a settlement was reached in 2006.  Teva subsequently released generic venlafaxine hydrochloride (immediate release) tablets in 2006 and generic extended release capsules in 2010, before the expiration of patents allegedly applicable to the products.